Business
Ondine CTO receives Lifetime Achievement Award
Ondine CTO receives Lifetime Achievement Award.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n \n \n \n Ondine's Dr. Nicolas Loebel receives IPA Lifetime Achievement Award for photodisinfection advancements\n \n \n \n Dr. Nicolas Loebel, President and Chief Technology officer of Ondine Biomedical Inc., has been awarded the 2022 Lifetime Achievement Award by the International Photodynamic Association (IPA) at the annual Photodynamic Therapy and Photodiagnostic (PDT-PDD) Symposium in Nancy, France. The Lifetime Achievement Award recognizes Dr. Loebel's significant contributions which have greatly advanced the emerging field of antimicrobial photodynamic therapy (aPDT), also known as photodisinfection.\n \n \n Dr. Loebel's research and development career spans over 20 years and has resulted in significant advancements in the science and clinical translation of aPDT, which is the foundation of Ondine Biomedical's nasal photodisinfection technology, Steriwave™.\n \n \n Dr. Loebel has been a leading force in the success of translating photodisinfection from bench to field, demonstrating safety, efficacy, and significant cost savings to healthcare systems. His pioneering work has led to numerous first-of-kind photodisinfection-based medical devices that prevent and treat multidrug-resistance infections without the use of antibiotics.\n \n \n \n \n \n \n About Nasal Photodisinfection\n \n \n \n \n \n Ondine's nasal photodisinfection\n \n \n comprises a two-step process: the application of a proprietary light-activated solution to each nostril using a nasal swab, followed by illumination of the area with a specific wavelength of laser light for less than five minutes.\n The photodisinfection\n process works by light exciting the photodynamic solution, causing an oxidative burst that is lethal to pathogens (Watch video here: \n \n \n www.ondinebio.com/technology\n \n \n )\n \n .\n \n A key benefit of this approach, unlike with antibiotics, is that pathogens do not develop resistance to the therapy.\n Photodisinfection is also known in the scientific community as antimicrobial photodynamic therapy (aPDT).\n \n \n Ondine's nasal photodisinfection has a CE mark for use in the EU and is approved in Canada and several other countries, including the UK, under the name Steriwave\n ™\n .\n In the US, it has received Qualified Infectious Disease Product designation and Fast Track status from the FDA and is currently undergoing...